Tirzepatide pens represent a breakthrough in peptide research for metabolic disorders. This innovative compound (LY3298176) acts as a dual GLP-1 and GIP receptor agonist, offering promising applications in weight management and glucose regulation studies.
Our Tirzepatide pens are manufactured under strict GMP conditions, ensuring consistent 99% purity for reliable research results. The lyophilized powder form provides excellent stability and convenient reconstitution for laboratory use.
As a novel peptide with molecular weight 4813 Da (C225H348N48O68), Tirzepatide demonstrates unique mechanisms of action compared to single-target agonists. Researchers appreciate its potential for studying complex metabolic pathways and developing new therapeutic approaches.
For scientific institutions and research facilities, we offer flexible ordering options including custom concentrations and bulk quantities. All shipments include comprehensive analytical documentation to support your research protocols.
Important Note: This product is intended for research purposes only. Not for human consumption or diagnostic use. Proper handling procedures should be followed by qualified researchers in controlled laboratory environments.